BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Colorcon
Harvard Business School
Chubb
Cipla
Cantor Fitzgerald
Mallinckrodt
Johnson and Johnson
Healthtrust

Generated: January 18, 2018

DrugPatentWatch Database Preview

Clozapine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for clozapine and what is the scope of clozapine freedom to operate?

Clozapine
is the generic ingredient in four branded drugs marketed by Tasman Pharma, Barr Labs Inc, Mylan Pharms Inc, Teva Pharms Usa, Jazz Pharms Iii, Accord Hlthcare, Aurobindo Pharma Ltd, Ivax Sub Teva Pharms, Mayne Pharma, Mylan, Par Pharm, Sandoz, Sun Pharm Inds Inc, and Heritage Life, and is included in fifteen NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Clozapine has forty patent family members in nineteen countries.

There are thirteen drug master file entries for clozapine. Fifteen suppliers are listed for this compound. There are two tentative approvals for this compound.
Pharmacology for clozapine
Medical Subject Heading (MeSH) Categories for clozapine
Tentative approvals for CLOZAPINE
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe25MGTABLET, ORALLY DISINTEGRATING;ORAL
➤ Subscribe➤ Subscribe100MGTABLET, ORALLY DISINTEGRATING;ORAL
➤ Subscribe➤ Subscribe100MGTABLET, ORALLY DISINTEGRATING;ORAL

US Patents and Regulatory Information for clozapine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms CLOZAPINE clozapine TABLET;ORAL 074949-004 Apr 25, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Accord Hlthcare CLOZAPINE clozapine TABLET;ORAL 202873-002 Nov 25, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan CLOZAPINE clozapine TABLET;ORAL 075417-003 Apr 15, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan CLOZAPINE clozapine TABLET;ORAL 075417-001 May 27, 1999 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz CLOZAPINE clozapine TABLET;ORAL 074546-002 Aug 30, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan CLOZAPINE clozapine TABLET;ORAL 075417-002 May 27, 1999 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-006 Jul 9, 2010 AB RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-006 Jul 9, 2010 AB RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-001 Feb 10, 2004 AB RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-002 Feb 10, 2004 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for clozapine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-002 Feb 10, 2004 ➤ Subscribe ➤ Subscribe
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-004 May 30, 2007 ➤ Subscribe ➤ Subscribe
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-002 Feb 10, 2004 ➤ Subscribe ➤ Subscribe
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-001 Feb 10, 2004 ➤ Subscribe ➤ Subscribe
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-003 Jun 3, 2005 ➤ Subscribe ➤ Subscribe
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-005 Jul 9, 2010 ➤ Subscribe ➤ Subscribe
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-003 Jun 3, 2005 ➤ Subscribe ➤ Subscribe
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-004 May 30, 2007 ➤ Subscribe ➤ Subscribe
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-006 Jul 9, 2010 ➤ Subscribe ➤ Subscribe
Jazz Pharms Iii FAZACLO ODT clozapine TABLET, ORALLY DISINTEGRATING;ORAL 021590-001 Feb 10, 2004 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for clozapine

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Fuji
Moodys
Federal Trade Commission
Medtronic
Daiichi Sankyo
Argus Health
UBS
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot